Featured Research

from universities, journals, and other organizations

Drugs Could Make Life-or-death Difference If Avian Flu Strikes

Date:
November 3, 2005
Source:
Cornell University
Summary:
In the absence of a specific avian flu vaccine, could antiviral drugs thwart a pandemic should the virus spread from birds to humans? One person with a detailed knowledge of that subject is Dr. Anne Moscona, an infectious-disease expert at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

Dr. Anne Moscona, an infectious-disease expert at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, is researching the use of antiviral drugs to combat a possible avian flu pandemic if the virus were to spread from birds to humans.
Credit: Image courtesy of Cornell University

In the absence of a specific avian flu vaccine, could antiviral drugs thwart a pandemic should the virus spread from birds to humans? One person with a detailed knowledge of that subject is Dr. Anne Moscona, an infectious-disease expert at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

Related Articles


In a review in the New England Journal of Medicine (Sept. 29), Moscona suggests that the right antiviral drugs and response plan will make a life-or-death difference should the avian virus spread to humans.

Moscona's review examines the four drugs currently available to treat influenza and outlines how antiviral drugs could be used to prevent a pandemic.

So far, avian flu has occurred mostly among Asian poultry workers who had direct contact with infected birds. However, in one possible case in Thailand researchers have suspected human-to-human transmission of the virus. And as infected birds continue to migrate, public health officials worry that an avian strain could become better at spreading between humans, making it uncontrollable.

If the virus does spread between people, doctors believe that antiviral drugs could reduce the severity of the influenza and protect those exposed from getting sick. Still, antiviral drugs need to be distributed and used cautiously, or an outbreak of influenza can actually be made much worse.

The Four Drugs to Combat Influenza

According to Moscona, the two classes of drugs to treat influenza are adamantanes and neuraminidase inhibitors.

"Adamantanes, the class of drugs that includes amantadine and rimantadine, are cheaper and more readily available," she says. "But they have some major drawbacks and would likely not be useful in an avian pandemic." Adamantanes are not effective against most of the avian flu viruses that have been isolated, and they can have serious side effects, such as seizures. Use of adamantanes can also encourage drug-resistant strains to emerge, and these strains can transmit from person to person.

"In most cases," says Moscona, "neuraminidase inhibitors are a better bet."

The class of neuraminidase inhibitors contains the drugs zanamivir and oseltamivir, although most consumers know them by their commercial names, Relenza and Tamiflu.

These drugs prevent the release of influenza virus from infected cells to healthy ones. They must be administered early before the virus infects too many cells, but they are highly effective at treating and protecting against all strains of influenza, including avian influenza.

Neuraminidase inhibitors are also associated with very little toxicity and are far less likely to promote the development of drug-resistant variants or strains. In a pandemic caused by avian influenza, neuraminidase inhibitors would likely be the only useful drug.

Neuraminidase inhibitors would have been effective against the virus that caused the 1918 influenza pandemic in which an estimated 25 million people worldwide died, and are effective against the avian viruses of 1997 to 1999, the avian viruses of 2004 and this year's avian viruses. The avian viruses are largely resistant to adamantanes.

But, there is also bad news about neuraminidase inhibitors. "There are not enough available to stop a pandemic, and there is little capacity to increase production in a time of need," says Moscona. She calls on agencies or nations to create stockpiles of neuraminidase inhibitors that can be quickly delivered to an outbreak. One idea is to develop international stockpiles managed by the World Health Organization.

Like water quenches a fire, neuraminidase inhibitors would be given to the sick as well as those who might have come in contact with them, creating "rings of prophylaxis" around outbreaks. Moscona prefers this to other responses, such as treating only the sick and health-care workers, or offering drugs as a prevention to those at high risk.

Why Not Vaccines?

With traditional influenza, health officials have become adept at anticipating what strains will surface and manufacturing vaccines accordingly. However, in a rapidly spreading pandemic caused by an unknown strain, vaccination is not a realistic plan.

For starters, vaccines require months to create. Scientists need to identify a virus and grow antibodies against it. Plus, the vaccine needs to be distributed, which takes time. A vaccine for the avian virus is being developed but none is yet available.

"In 2005, the tools to detect and diagnose an influenza outbreak are better than they have ever been," says Moscona. "Doctors now have highly effective drugs to treat existing cases and safeguard against others developing."

Unfortunately, individuals can still carry and spread influenza before showing any symptoms, and with modern transportation, an infected person in country "A" can board a flight, mingle with other passengers, and soon countries "B," "C" and "D" have cases to deal with.

"Rapid transit makes curbing an outbreak harder," says Moscona, who thinks a pandemic is likely to happen some year, but is less gloomy about the outcome. She thinks that many people can be protected if scientists keep developing new antiviral drugs and governments improve their public health infrastructure. "But this has to be made a priority in every country because what's 'over there' is no longer so far away."


Story Source:

The above story is based on materials provided by Cornell University. Note: Materials may be edited for content and length.


Cite This Page:

Cornell University. "Drugs Could Make Life-or-death Difference If Avian Flu Strikes." ScienceDaily. ScienceDaily, 3 November 2005. <www.sciencedaily.com/releases/2005/11/051103081237.htm>.
Cornell University. (2005, November 3). Drugs Could Make Life-or-death Difference If Avian Flu Strikes. ScienceDaily. Retrieved April 1, 2015 from www.sciencedaily.com/releases/2005/11/051103081237.htm
Cornell University. "Drugs Could Make Life-or-death Difference If Avian Flu Strikes." ScienceDaily. www.sciencedaily.com/releases/2005/11/051103081237.htm (accessed April 1, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, April 1, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

7-Year-Old Girl Gets 3-D Printed 'robohand'

7-Year-Old Girl Gets 3-D Printed 'robohand'

AP (Mar. 31, 2015) — Although she never had much interest in prosthetic limbs before, Faith Lennox couldn&apos;t wait to slip on her new robohand. The 7-year-old, who lost part of her left arm when she was a baby, grabbed it as soon as it came off a 3-D printer. (March 31) Video provided by AP
Powered by NewsLook.com
Solitair Device Aims to Takes Guesswork out of Sun Safety

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) — The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins